Compare KURA & FBRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KURA | FBRT |
|---|---|---|
| Founded | 2014 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 830.1M | 882.8M |
| IPO Year | N/A | 1985 |
| Metric | KURA | FBRT |
|---|---|---|
| Price | $8.99 | $10.26 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 3 |
| Target Price | ★ $26.88 | $14.33 |
| AVG Volume (30 Days) | ★ 1.4M | 641.6K |
| Earning Date | 02-25-2026 | 02-11-2026 |
| Dividend Yield | N/A | ★ 13.87% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.80 |
| Revenue | $104,029,000.00 | ★ $241,051,000.00 |
| Revenue This Year | $109.64 | $28.41 |
| Revenue Next Year | $62.82 | $58.29 |
| P/E Ratio | ★ N/A | $12.82 |
| Revenue Growth | N/A | ★ 32.77 |
| 52 Week Low | $5.41 | $9.65 |
| 52 Week High | $12.49 | $13.58 |
| Indicator | KURA | FBRT |
|---|---|---|
| Relative Strength Index (RSI) | 40.65 | 51.04 |
| Support Level | $8.13 | $10.07 |
| Resistance Level | $9.43 | $10.37 |
| Average True Range (ATR) | 0.49 | 0.22 |
| MACD | -0.07 | 0.04 |
| Stochastic Oscillator | 36.42 | 79.97 |
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. Its segments include the real estate debt business; the real estate securities business; the real estate owned business; and the commercial real estate conduit business.